Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by ragingbull1234 on Feb 25, 2016 9:45am

Volume.

15 minutes into trading and $40.50 Canadian have traded hands.  :)
Comment by ragingbull1234 on Feb 25, 2016 10:10am
What kind of dummies would accept a BLA, set an absurdly overextended date of 6-months, call it priority review, and then after 5 full months of "assessment", can't make a yes or no decision when their OWN PEOPLE THAT HAVE PAID THEIR SALARIES FOR YEARS, sit around dying of cancer without any options but bladder removal.   It's no wonder that the rest of the world can't ...more  
Comment by Gary1959 on Feb 25, 2016 12:28pm
Yes so true
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities